Market Rank #17 · Evidence Tier A

Poland
Neuroscience Intelligence

Poland neuroscience intelligence: 210 indexed trials, 52 institutions, research score 40.77.

⚗
210Indexed trials
↗
56Recruiting
⌂
52Research institutions
◎
40.8Research score

Evidence profile

103Sponsors
26Disease areas
0Institution works
0Institution citations

Evidence signals

Research score 40.8 · Data confidence 100.00 · Evidence 40.8

Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.

Leading disease areas

parkinsons42trials
epilepsy33trials
alzheimers26trials
multiple_sclerosis20trials
other_neurology12trials
depression11trials
neuromuscular10trials
pain_neuropathy7trials
schizophrenia7trials
adhd6trials

Leading indexed sponsors

Merck Sharp & Dohme LLC23trials
Hoffmann-La Roche17trials
Boehringer Ingelheim8trials
Jazz Pharmaceuticals7trials
UCB Pharma5trials
H. Lundbeck A/S5trials
Biogen5trials
Novartis Pharmaceuticals4trials
Eli Lilly and Company4trials
Amgen3trials